Is It Possible to Recover Erectile Function Spontaneously after Cavernous Nerve Injury? Time-Dependent Structural and Functional Changes in Corpus Cavernosum Following Cavernous Nerve Injury in Rats

Purpose: There has been a scarcity of integrated, long-term (>4 week) studies on structural and functional alterations in the penis according to the period following cavernous nerve (CN) injury. The aim of this study was to investigate time-dependent structural and functional changes in the corpus cavernosum following CN injury in a rat model. Materials and Methods: Ninety male Sprague-Dawley rats (10 weeks old) were divided into 4 groups: normal control (C), sham (S), bilateral CN resection (R), and bilateral CN crush injury (I) groups. At 1, 4, and 12 weeks after the procedure, erectile function was assessed by electrostimulation. The terminal deoxynucleotidyl transferase-mediated 2’-deoxyuridine 5’-triphosphate nick end labeling (TUNEL) assay was performed for detection of apoptosis. Masson’s trichrome staining and immunohistochemistry were performed for detection of alpha smooth muscle actin (α-SMA). Western blot analysis was then performed. Results: The R and I groups showed persistent impairment of erectile function at all three points in time. Apoptosis peaked at 1 week after resection or crush injury and then gradually subsided. The smooth muscle cell/collagen ratio and expression of α-SMA gradually decreased over time after CN resection or crush injury. Myosin phosphatase target subunit 1 phosphorylation progressively increased over time after CN resection or crush injury. On the other hand, expression of phospho-protein kinase B, phospho-endothelial nitric oxide synthase, and neuronal nitric oxide synthase transiently decreased at 1 week after resection or crush injury and then recovered to the control values. Conclusions: Our results suggest that persistent up-regulation of the RhoA/Rho-kinase pathway and structural change such as decreased smooth muscle cell and increased cavernosal fibrosis might play an important role in persistent erectile dysfunction following CN injury.

[1]  조용현,et al.  만성 세균성 전립선염 흰쥐 모델에서 셀레늄 함유 온천수 음용의 항염 및 항균효과 , 2012 .

[2]  조용현,et al.  전립선비대증 환자에서 베아자트 Ⓡ 엑스엘정 (alfuzosin 10 mg)의 안전성과 유효성에 대한 1차의료기관의 전향적 다기관 평가 , 2012 .

[3]  H. J. Kim,et al.  Spontaneous Recovery of Cavernous Nerve Crush Injury , 2011, Korean journal of urology.

[4]  Zhan-sheng Zhao,et al.  Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes , 2011, Acta Pharmacologica Sinica.

[5]  Yongjun Li,et al.  Fasudil hydrochloride hydrate, a Rho‐kinase inhibitor, suppresses high glucose‐induced proliferation and collagen synthesis in rat cardiac fibroblasts , 2011, Clinical and experimental pharmacology & physiology.

[6]  M. Cho,et al.  Involvement of sphingosine-1-phosphate/RhoA/Rho-kinase signaling pathway in corporal fibrosis following cavernous nerve injury in male rats. , 2011, The journal of sexual medicine.

[7]  J. Paick,et al.  Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats. , 2011, The journal of sexual medicine.

[8]  C. Stief,et al.  Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats. , 2010, The Journal of urology.

[9]  J. Han,et al.  A mouse model of cavernous nerve injury-induced erectile dysfunction: functional and morphological characterization of the corpus cavernosum. , 2010, The journal of sexual medicine.

[10]  T. Ishimitsu,et al.  Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction , 2010, Hypertension Research.

[11]  A. Shindel Chronic Treatment with a Type 5 Phosphodiesterase Inhibitor Suppresses Apoptosis of Corporal Smooth Muscle by Potentiating Akt Signalling in a Rat Model of Diabetic Erectile Dysfunction , 2009 .

[12]  C. Abbou,et al.  Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunction. , 2009, European urology.

[13]  K. Park,et al.  Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis , 2009, International Journal of Impotence Research.

[14]  M. Ferrini,et al.  Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. , 2009, The journal of sexual medicine.

[15]  J. Mulhall Penile rehabilitation following radical prostatectomy , 2008, Current opinion in urology.

[16]  A. Burnett,et al.  FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. , 2007, The journal of sexual medicine.

[17]  A. Burnett,et al.  eNOS Function and Dysfunction in the Penis , 2006, Experimental biology and medicine.

[18]  A. Burnett,et al.  Erection Capability Is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric-Oxide Synthase Phosphorylation , 2005, Molecular Pharmacology.

[19]  Philip S Li,et al.  The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. , 2005, The journal of sexual medicine.

[20]  F. Montorsi,et al.  Erectile dysfunction after radical prostatectomy , 2004, BJU international.

[21]  K. McVary,et al.  Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. , 2003, The Journal of urology.

[22]  H. Shimokawa,et al.  Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. , 2002, European journal of pharmacology.

[23]  J. Hotaling,et al.  Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. , 2002, The Journal of urology.

[24]  T. Lue,et al.  IGF-I and TGF-β2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats , 1999, International Journal of Impotence Research.

[25]  J. Mulhall,et al.  The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. , 1996, International journal of impotence research.

[26]  鷲田 直輝 Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis , 2011 .

[27]  Philip S Li,et al.  Functional sequelae of cavernous nerve injury in the rat: is there model dependency. , 2006, The journal of sexual medicine.

[28]  T. Moriyama,et al.  The Rho-ROCK system as a new therapeutic target for preventing interstitial fibrosis. , 2004, Drug news & perspectives.

[29]  A. Burnett,et al.  Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. , 2004, The Journal of urology.

[30]  P. Walsh,et al.  Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. , 2000, Urology.